First Prospective Multicenter Italian Study on the Impact of the 21‐Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer

BACKGROUND. The Breast DX Italy prospective study evaluated the impact of the 21‐gene recurrence score (RS) result on adjuvant treatment decisions for patients with early breast cancer. MATERIALS AND METHODS. Nine centers (two Hub and seven Spoke centers of the Veneto Oncology Network) participated....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Principais autores: Dieci, Maria Vittoria, Guarneri, Valentina, Giarratano, Tommaso, Mion, Marta, Tortora, Giampaolo, De Rossi, Costanza, Gori, Stefania, Oliani, Cristina, Merlini, Laura, Pasini, Felice, Bonciarelli, Giorgio, Griguolo, Gaia, Orvieto, Enrico, Michieletto, Silvia, Saibene, Tania, Del Bianco, Paola, De Salvo, Gian Luca, Conte, PierFranco
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905682/
https://ncbi.nlm.nih.gov/pubmed/29133514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0322
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados